Press Release

November 03, 2026 To To The Listing Department, The Corporate Relations Department, National Stock Exchange of India Limited BSE Limited NSE Symbol: VIJAYA BSE Scrip Code: 543350 Dear Sir/Madam, Subject: Press Release on Financial Results – Q2 FY2027 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the “Press Release on Q2 FY2027 Results” being issued by the Company. Kindly take the same on record. Thanking You. Yours faithfully, For Vijaya Diagnostic Centre Limited Narasimha Raju K A Chief Financial Officer Encl.: As above Regd. Office - 6-3-883/F, FPA Building, Near Topaz Building, Punjagutta, Hyderabad-500082, Telangana, India Vijaya Diagnostic Centre Ltd announces Q2 & H1 FY27 results, with a strong 26.7% YoY revenue growth Hyderabad, November 3, 2026: Vijaya Diagnostic Centre Limited (NSE: VIJAYA, BSE: 543350), one of India’s leading integrated diagnostic chains, has announced its financial results for the quarter ended 30th September 2026. Consolidated Financial Performance: Particulars (Rs. Mn) Q2FY27 Q2FY26 YoY % H1FY27 H1FY26 YoY % Revenue from 2,553.9 2,015.6 26.7% 4,863.7 3,896.1 24.8% Operations EBITDA 1,127.5 818.3 37.8% 2,112.9 1,553.6 36.0% EBITDA Margin (%) 44.1% 40.6% 355 bps 43.4% 39.9% 357 bps Profit after Tax 594.7 432.8 37.4% 1,125.7 818.7 37.5% (PAT) PAT Margin (%) 23.3% 21.5% 181 bps 23.1% 21.0% 213 bps Operational Highlights: In millions, unless otherwise specified Particulars Q2FY27 Q2FY26 YoY % H1FY27 H1FY26 YoY % Total Tests 4.98 4.28 16.5% 9.57 8.22 16.5% Total Footfall 1.37 1.20 14.5% 2.61 2.30 13.7% Tests per Footfall 3.64 3.57 1.7% 3.67 3.58 2.5% Avg realization per 513 471 8.8% 508 474 7.2% test (Rs) Avg realization per 1,865 1,685 10.6% 1,862 1,696 9.8% Footfall (Rs) Wellness share % 14.5% 14.4% 4 bps 14.6% 14.3% 29 bps Commenting on the Business Outlook, Ms. Suprita Reddy, MD & CEO said “I am pleased to share that we have sustained our strong growth momentum during Q2 FY27, delivering 26.7% year- on-year revenue growth, supported by 16.5% volume growth. Our existing centres grew by approximately 20%, while newer centres continued to ramp up well. Our core markets maintained strong momentum, while Pune has been witnessing a meaningful turnaround with consistent double-digit growth since few quarters. We continue to see encouraging momentum in West Bengal, as our brand awareness strengthens. We are particularly pleased with the response in Tier-II markets such as Krishnanagar and Diamond Harbour. On the expansion front, we have commissioned 2 hubs and 7 spokes so far during FY27. Looking ahead, we expect to commission another 3 hubs & 7 spokes in H2 FY27, followed by 3 additional hubs in Q1 FY28, further strengthening our network and expanding our presence across key markets. Page | 1 During the quarter, we entered into Business Transfer Agreement to acquire Arya Wellness Centre in Guwahati, Assam. This marks our entry into the North-East region and is an important step towards expanding our geographical presence beyond our existing markets. We believe this acquisition provides us with a strong platform to establish our presence in Guwahati and gradually explore further growth opportunities across the North-East, leveraging our expertise in integrated diagnostics and operational excellence. We remain committed to strengthening our presence across key markets, investing in advanced technology and delivering high-quality diagnostic services to support sustainable long-term growth.” About Us: Vijaya Diagnostic Centre Limited (Vijaya), is one of India’s largest integrated diagnostic chains, providing one-stop solution for pathology and radiology investigations through an extensive operational network spanning 165+ diagnostic centres and 29 reference laboratories in 27 cities and towns spread across Telangana, Andhra Pradesh, Maharashtra, Karnataka, NCR and West Bengal. The company offers comprehensive diagnostic services ranging from basic pathology to high-end radiology. Corporate Identification No: L85195TG2002PLC039075 Regd. Office: 6-3-883/F, FPA Building, Near Topaz Building, Punjagutta, Hyderabad-500082, Telangana, India. For more information, please visit www.vijayadiagnostic.com OR contact: Mr. Dhiren Gala Head of Investor Relations & Corporate Development Vijaya Diagnostic Centre Limited Tel: +91 90598 93206 Email: dhiren.g@vijayadiagnostic.in ir@vijayadiagnostic.in DISCLAIMER: Certain statements that may be made in the press release may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like significant changes in economic environment in India and overseas, tax laws, import duties, litigation, labour relations etc. Actual results might differ substantially from those expressed or implied. Vijaya Diagnostic Centre Limited will not be in any way responsible for any action taken based on such statements and discussions; and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances. Page | 2